4 results match your criteria: "St Vincent's Centre for Applied Medical Research University of New South Wales[Affiliation]"
Impact of Draf III, Draf IIb, and Draf IIa frontal sinus surgery on nasal irrigation distribution.
Int Forum Allergy Rhinol
January 2020
Rhinology and Skull Base Research Group, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, NSW, Australia.
Background: Delivery of topical pharmacotherapy to the paranasal sinuses remains integral to the management of chronic rhinosinusitis. The frontal sinus remains a difficult access site for irrigations, often limited by its position relative to the nostril and ethmoid sinus. In view of the previous demonstration of improved frontal sinus irrigation with Draf III vs Draf IIa, in this work we sought to evaluate topical access of Draf IIb relative to Draf IIa and Draf III modification of the frontal sinus outflow tract.
View Article and Find Full Text PDFHigh-risk coronary plaque, invasive coronary procedures, and cardiac events among HIV-positive individuals and matched controls.
J Cardiovasc Comput Tomogr
April 2017
University of Notre Dame, Sydney, Australia; St. Vincent's Hospital, Sydney, Australia; Victor Chang Cardiac Research Institute, Sydney, Australia.
Background: Human immunodeficiency virus (HIV) infection is considered a chronic, treatable disease, although treatment is associated with increased rates of coronary artery disease (CAD). We analyzed the utility of coronary CTA in the assessment of CAD among HIV patients and explored whether HIV patients are at greater risk of associated morbidity and mortality compared to HIV-negative controls.
Methods: In a retrospective, single center cohort study 97 males without history of previous coronary artery disease who had undergone coronary CTA between 2011 and 2014 was analyzed, including 32 HIV positive patients and 65 matched HIV negative controls.
The prognostic value of TP53 mutations in oesophageal adenocarcinoma: a systematic review and meta-analysis.
Gut
March 2017
Gastroesophageal Cancer Program, St Vincent's Centre for Applied Medical Research University of New South Wales, Sydney, New South Wales, Australia.
Objective: To clarify the prognostic role of tumour protein 53 (TP53) mutations in patients with oesophageal adenocarcinoma (OAC) as there is a need for biomarkers that assist in guiding management for patients with OAC.
Design: A systematic review was conducted using MEDLINE, Embase, PubMed and Current Contents Connect to identify studies published between January 1990 and February 2015 of oesophageal cancer populations (with OAC diagnoses >50% of cases) that measured tumoural TP53 status and reported hazard ratios (HR), or adequate data for estimation of HR for survival for TP53-defined subgroups. Risk of bias for HR estimates was assessed using prespecified criteria for the appraisal of relevant domains as defined by the Cochrane Prognosis Methods Group including adherence to Grading of Recommendations, Assessment, Development and Evaluation and REporting recommendations for tumor MARKer prognostic studies guidelines, as well as assay method used (direct TP53 mutation assessment vs immunohistochemistry) and adjustment for standard prognostic factors.
Response to the modeling analysis by Katz et al. on the impact of replacing clinic-based HIV tests with home testing among men who have sex with men in Seattle.
Sex Transm Dis
May 2014
The Kirby Institute University of New South Wales Sydney, NSW 2052 Australia The Kirby Institute University of New South Wales Sydney, NSW 2052 Australia St Vincent's Centre for Applied Medical Research University of New South Wales Sydney, NSW 2052 Australia The Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.